faculty of 1000

Post-publication peer review

Archive for the ‘Medicine’ Category

Effects of a continuous work-flow on residents in the intensive care unit

Posted by Callum Anderson on 11 March, 2010

It is well known that the average physician in training will be expected to work more than a few 24 hour shifts during their training. It is also well known that sleep deprivation affects performance (how much? Now that’s the real question, but I digress).

I read a paper, evaluated by Faculty of 1000 member Samuel Ajizian, in which a team of scientists led by R Sharpe at the University of British Columbia have studied the effects of a continuous work-flow on residents in the intensive care unit.

Although monitoring performance of sleep deprived workers is a popular research subject (see, here, here and here), there are a couple of nice aspects to this study. Firstly, the use of a realistic total patient simulation is novel to this type of study; much of the previous body of research has focussed on more general cognitive testing and surgical simulators. The participants also assessed their own performance at various stages of the study allowing the researchers to see if the physicians could notice a drop in performance for themselves.

The simulation included performing advanced cardiac life support scenarios and management of a simulated critically ill patient.

I could spot a potential problem with this paper however. And I was not surprised to read the following statement

For the advanced cardiac life support scenarios, the mean number of major errors committed… decreased during the study period.

We have what looks like (and is subsequently judged to be) a significant ‘learning effect’, and I am surprised the team couldn’t have found a way to assuage this, perhaps by demonstrating the simulation and training physicians before observation?

Results from the patient management scenario followed expectation

The mean number of errors went up from 0.92 +/- 0.90 in the first session to 1.58 +/- 0.79 in the fourth session (p = 0.9).

Another interesting aspect of this study was that Sharpe and his team asked the physicians to conduct subjective self assessment at various stages. Compare the following results of personally assessed global score (again from patient management) with the number of errors displayed above

mean global score decreased from 56.8 ± 14.6 to 49.6 ± 12.6 (p = .02).

A discrepancy between the mean number of errors and the mean global score can be seen here, strongly suggesting that our ability to judge personal performance is not nearly as accurate at hour 20 as it is at hour 1.

Although I wouldn’t like to make any serious judgements from this paper alone, I think there is significant room for further research in this area, especially using realistic patient simulation.

Ajizian also noted in his evaluation that it would be interesting to [repeat this study and allow the residents unlimited access to their preferred caffeine source].

Doing so might provide us with some better data, especially as we tend to work under the influence of caffeine even when we aren’t particularly tired. I wonder if performance levels might correlate to the intensity or the type of stimulant used. Perhaps coffee offers a greater mental boost for physicians than tea? Any anecdotal evidence is welcome below.

Sharpe R, Koval V, Ronco JJ, Dodek P, Wong H, Shepherd J, Fitzgerald JM, Ayas NT. The impact of prolonged continuous wakefulness on resident clinical performance in the intensive care unit: a patient simulator study. Crit Care Med 2010 38:766-70

Posted in Medicine, f1000 | Tagged: , , | Leave a Comment »

Have we overlooked the drinking cup?

Posted by Callum Anderson on 3 March, 2010

One of the things I love about scientific knowledge is that it is always in a state of flux. Theories are constantly being amended, rejected or confirmed by the community. In short, there is always room for more research regardless of how well trodden the ground may be.

In this vein, I read an interesting paper, evaluated by Faculty of 1000 member Phil Fischer (link to evaluation free for 3 months).

Simonne Rufener and a team based jointly at the University of Bern, Swiss Tropical Institute in Basel and Institute of Aquatic Sciences and Technology at Dübendorf have published a field study which expands significantly on previous research.

Every year, some 1.6 million people die due to diarrhoea associated with contaminated drinking water. In countries without running water, where drinking water must be collected at source, plenty of research has shown that the water is often contaminated at various stages before consumption, even if the source is relatively free from contamination (see here, here, and here).

The paper hypothesizes that in-house recontamination of drinking water after treatment is a significant, often overlooked problem in the developing world. The team visited 81 households in Bolivia and took 347 water samples from current sources, treated water, transport vessels and drinking vessels. Looking at levels of E. coli at various stages of the water journey, the Rufener and his team were able to show that disinfection at source, or even at home prior to consumption, did not effectively reduce bacteria levels. In fact the paper makes the point that even after home based water treatment such as boiling or SODIS

Only 36% of the treated water samples were free from E. coli

The real conclusion to acknowledge is that disinfecting water at source or at home will continue remain a relatively ineffective treatment while the majority of drinking vessels are still contaminated with E. coli. In the future, we may find solutions which combine water-source interventions, with effective hygiene education to help reduce levels of bacteria in the drinking cup itself.

Rufener S et al J Health Popul Nutr 2010 28 :34-41

Posted in Medicine, f1000 | Tagged: , , , , | Leave a Comment »

Is there an alternative?

Posted by Callum Anderson on 19 February, 2010

I read an article recently in a well-known London newspaper which raised an issue I have been thinking about for a long time. What happens when unregulated medicine actually causes more harm than good?

I won’t name names (although the original article does), but in a nutshell, a woman was prescribed pills by a practitioner of Chinese medicine containing the (subsequently banned) substance [aristolochic acid] to treat her acne. On the one hand the pills did their job, and the acne cleared up, but on the other hand they were destroying her kidneys, inducing urinary tract cancer and eventually led to a heart attack. The woman now needs dialysis treatment three times a week and is no longer able to work.

The problem here stemmed from the fact that the sale of Chinese medicine is completely unregulated, and it is pretty unlikely that a practitioner selling the pills is going to have a subscription to Mutagenesis, in which a 2002 article reported the following

It is concluded that there is significant evidence that AA is a powerful nephrotoxic and carcinogenic substance with an extremely short latency period, not only in animals but also in humans. In particular, the highly similar metabolic pathway of activation and resultant DNA adducts of AA allows the extrapolation of carcinogenesis data from laboratory animals to the human situation. Therefore, all products containing botanicals known to or suspected of containing AA should be banned from the market world wide.

And anyway, this study proved to be too little, too late. By the time the ban was in place, the woman had been taking the pills for a little over five years, and the damage was irreversible.

Now I’m not suggesting that we should blanket ban alternative therapies because of one mistake (albeit a pretty huge one). And as my esteemed colleague RPG has previously noted, many alternative remedies have active ingredients which really do work.

However, I can’t help feeling that if alternative medicine (and I use the term ‘medicine’ with the lightest touch) wants to be taken seriously, it really needs to become self-regulating, and ensure things like this can’t happen again.

What form might that regulation take? Well for a start we could insist that all practitioners of alternative medicine are registered with and accredited by their respective council. For Chinese medicine this would be The Chinese Medicine Council, UK. Secondly we need to give these independent bodies real power, the ability to blacklist practitioners and ban substances without exception, and ensure that the medicine suppliers are subject to rigorous product testing before bringing new products to market.

Posted in Medicine, f1000 | Tagged: , | Leave a Comment »

Food for thought

Posted by Callum Anderson on 17 February, 2010

A recent evaluation on Faculty of 1000 Biology highlights a novel advance in the fight against adolescent obesity.  In what could be considered the first behavioural trial to treat obesity (i.e. not based on a drug treatment), a team led by Anna L Ford at The Bristol Care of Childhood Obesity Clinic found that by retraining the eating habits of obese patients, sustained weight loss can be achieved.

The trial centres around a new technology called the Mandometer, which has previously been marketed as a device to cure Anorexia-Bulimia.

Mildly humorous instructional video.

The device is essentially a set of weighing scales, linked to a computer, which monitors how much you are eating and how fast you are eating it. Participants record how full they feel on a 100 point scale at various times throughout the meal, and the device then tells them to eat more slowly or quickly depending on their answers.

In recent years, we have come to redefine Anorexia-Bulimia as a behavioural or psychological rather than a medical condition. This study puts forward the argument that it may well be time to look at obesity in the same manner.

As the authors say

An intervention aimed at slowing down speed of eating and reducing portion size through retraining eating behaviour is a useful adjunctive therapy to standard lifestyle modification in obese adolescents.

Now it isn’t particularly surprising that when told what to eat, and how quickly to eat it, the trial participants lost weight. Nor is the conclusion that behavioural based eating interventions are a good way to sustain weight loss a real revelation. However this trial does offer some hope for making sure that patients retain a healthy weight after observation has ended, mainly because the device can be used at home and without supervision. Perhaps technology based solutions may provide a fruitful area of study in the future?

Posted in Literature, Medicine, f1000 | Tagged: , , , | 4 Comments »

On the run-12Feb10

Posted by rpg on 12 February, 2010

Cancer Causes Cancer!

Well, that was the headline we should have gone with. It is of course a hat tip to the Daily Mail, a tabloid publication that is desperate to tell the UK population that just about everything causes cancer. (I found that website by googling ‘cancer causes daily mail’, which is in itself quite a neat headline. Unfortunately I think we’re closer to curing cancer than curing the Daily Mail. Oh well.)

So, we know that tumours have this nasty habit of sending out malignant cells into the rest of the body. They break off from the primary site and get into the blood and lymphatic systems, occasionally washing up in convenient organs where they can settle down and create new tumours, or metastases. This is partly why cancer is so difficult to cure: you can cut out the original malignant growth, zap it with X-rays and take all sorts of evil drugs (‘evil’ because they are designed to kill cells, and you’re made up of cells; and discrimination between the cancer cells and normal cells is a huge problem); but if one metastatic cell survives, you have to start all over again. And if it’s managed to find a home deep in a bone, or the brain, or somewhere equally inaccessible, it’s game over.

It turns out things are even worse than that. Circulating tumour cells, if they find their way back to their original ‘home’, can actually stimulate growth of the original cancer. Nasty. As the authors say,

Tumor self-seeding could explain the relationships between anaplasia, tumor size, vascularity and prognosis, and local recurrence seeded by disseminated cells following ostensibly complete tumor excision.

‘Ostensibly complete tumor excision’—that’s right, because no matter how good your surgeon is, you can never be sure you’ve cut every last bit out; or that some cells haven’t already gone walkabout.

The good news is that certain cytokines derived from the tumour, IL-6 and IL-8, act to attract the circulating cells, and that they get back in via the matrix metalloproteinase collagenase I (MMP-1) and fascin-1 (it’s the actin cytoskeleton again! These guys get everywhere). If we can find a way to selectively block these pathways we should be able to start thinking about appropriate therapeutic approaches. Gentlemen (and ladies), start your (grant-writing) engines.

Kim, M., Oskarsson, T., Acharyya, S., Nguyen, D., Zhang, X., Norton, L., & Massagué, J. (2009). Tumor Self-Seeding by Circulating Cancer Cells Cell, 139 (7), 1315-1326 DOI: 10.1016/j.cell.2009.11.025

Twitter storm

It’s been pretty hectic on the twittertubes this week. Following a random conversation at the Scholarly Kitchen I suggested writing papers in 140 characters would be a wheeze. I turned it into a competition, and we had an amazing response. Check back on Monday to find out who’s the lucky winner of a bag of f1000 swag.

Badger Wars

vermin shooting verminI don’t have a lot to say about badger culling to prevent/reduce bovine TB (except maybe to say that killing vermin with a high-powered rifle and decent ’scope is one of the most humane ways of doing this).

I just like the sound of a ‘randomized badger culling trial’. Oh, and when someone ‘explains’

This trial was undertaken in very specific circumstances and it could be misleading to extrapolate the findings to any future control program.

you can be pretty sure there’s a vested interest or extreme prejudice somewhere. Even when the trial shows that there’s no economic benefit.
Jenkins, H., Woodroffe, R., & Donnelly, C. (2010). The Duration of the Effects of Repeated Widespread Badger Culling on Cattle Tuberculosis Following the Cessation of Culling PLoS ONE, 5 (2) DOI: 10.1371/journal.pone.0009090

Valentine’s Day

Just a reminder to all you chaps out there—it can’t hurt to buy some flowers, even if you don’t want to buy into the whole commercialization thing. A nice dinner doesn’t cost you much either, and could pay dividends in the romance stakes. But at the very least, show you really care by getting checked out:

Take a test for #Valentine’s Day. Sexual health appointments across Lincolnshire within 48 hours. Call 01522 539 145

It gets pretty lonely up there in Lincolnshire. Have a good weekend, and I hope it’s full of lovehearts and kisses. Failing that, a beer or three can have much the same effect.


Posted in Friday afternoon, Literature, Medicine, Random, Science | Tagged: | 1 Comment »

Money

Posted by rpg on 21 January, 2010

The distribution and uptake of antivirals and vaccination was in the news quite a bit before Christmas. H1N1 swine flu didn’t turn out to be the Armageddon some commentators were forecasting, but I don’t think it’s overstating the case to say that we dodged a bullet there. In cases like this we might expect the government to give a clear message, based on the best possible epidemiology. No, please, stop laughing. After all, the UKian government was right about the MMR combined vaccine, even if they did handle the situation incredibly poorly.

And that’s a problem, isn’t it? In our culture we don’t trust what the government tell us anymore. That may or may not be a good thing, but it certainly creates problems for public health policy, especially in a potential epidemic situation. Sometimes it’s quite clear what the right thing to do is, but how do we get them to do it?

A paper just published in PNAS and reviewed on f1000 (link free for three months) sets out an economic framework for controlling transmissible and evolving diseases. Now, I’m not an epidemiologist (you should possibly go and talk to my mate Bill if you’re that interested), and the argument therein apply more to a healthcare system that is not free at point of care (Obama’s reforms notwithstanding), but it’s an interesting paper nonetheless.

Antibiotic treatment for otitis media

“public policies such as taxing and subsidizing goods are frequently used to correct (for public benefit) the private actions of individuals when externalities, or side effects, of these actions exist.”

By comparing four different scenarios and addressing negative externalities, the authors predict where financial dis/incentives should be applied for maximum public health benefit. The scenarios discussed here are

  1. Tetanus: infectious but not transmissible between humans, and no herd immunity
  2. Measles: infectious, effective vaccination that generates a herd effective by reducing transmission
  3. Otitis media: non-transmissible, but unnecessary antibiotic treatment can lead to the negative externality of antibiotic resistance
  4. Pandemic influenza: antiviral treatment generates negative (resistance) and positive (reduced transmission) externalities.

Antiviral treatment for pandemic flu

There’s a whole heap of math in this paper, and although (or perhaps because) I’m supposed to be coming up with robust formulae for our rankings on the main site, it makes my brain hurt.

I find the thesis that economic impact can be leveraged to get maximum public health benefits an interesting one. I’m not sure how that would apply to the UK, for example, where the cost of healthcare is more-or-less invisible.

Infectious diseases tend to evolve quite rapidly when we attempt to control them, whether we use antibiotics, other drugs or prophylactic vaccinations. The framework expounded in this paper should prove to be readily applicable to a wide range of such diseases. Assuming, of course, that the authorities responsible for public health have the appropriate fiscal executive power, and access to current and accurate scientific information…

Read the rest of this entry »

Posted in Literature, Medicine | Tagged: , , , , , , , , , , , | Leave a Comment »

Here we go again

Posted by rpg on 19 January, 2010

CAM is a group of diverse medical and health care systems, practices, and products that are not generally considered to be part of conventional medicine. While scientific evidence exists regarding some CAM therapies, for most there are key questions that are yet to be answered through well-designed scientific studies—questions such as whether these therapies are safe and whether they work for the purposes for which they are used.

So says the US National Institutes of Health about ‘complementary and alternative’ medicine. What the NIH doesn’t tell you is that some people get quite ratty, and indeed irrational, when talking about it. It also fails to point out that that if something doesn’t work it can hardly be called ‘medicine’, so the phrase ‘complementary and alternative medicine’ is a bit pointless.

Yes, I know: CAM means anything that isn’t ‘Western’ medicine, the stuff that often has huge amounts of evidence behind it and that actually makes people better. Or maybe anything that isn’t pouring money into the coffers of multinational pharmaceutical companies—as if that’s somehow worse than pouring money into the coffers of those who offer sugar pills and countless different vitamin formulations.

Anyway, the point is that anything that claims to be a medicine can be tested, to see if it actually does make people better. Isn’t that what we’re trying to do? Anyone who tells you that a CAM therapy can’t be tested is lying to you, and by the way, when did you last see your wallet? The endpoint for all medicines or treatments is really quite simple: does someone who is unwell get better as a result? Where things get complicated is in the testing protocols you use: in defining ‘better’; in the appropriate choice of controls; in statistical analysis; in dosage; and indeed in defining what ‘unwell’ means in each case. (It’s trivial to feel a bit run down, take some supplement or do yoga and feel better again, and say that the intervention worked; when in fact you had just had a couple of bad nights’ sleep. This is why the plural of ‘anecdote’ isn’t ‘data’.)

More problems arise when people start getting lazy and lumping together things like herbalism and acupuncture with homeopathy. One of those involves chemicals extracted from plants, one involves a surgical procedure; and one nothing at all. It makes no sense at all to compare them as equals. (Now you might say that homeopaths treat the patient and not the condition, and you might well be right; but conventional medicine also has that. It’s called ‘bedside manner’ and it’s very powerful.) Now, I have no particular beef with homeopathy per se: if educated, well-informed people want to try it, then that’s their lookout. But when people in positions of authority or responsibility actively deny access to ‘conventional’ medicines that actually work, in favour of witchcraft, I get a bit tetchy.

We talked a week or two ago about a study that looked at a herbal remedy; chamomile. There, chamomile came out as beneficial in cases of mild anxiety. This was a nicely done trial, with a result that wasn’t really surprising. After all, people have been using it for ages (and noticed an effect; presumably if they hadn’t they’d stop buying it) and there’s actually some chemical in it that has a chance of being biologically active. Chamomile tea might well be classified as a CAM, and it works. We can call it ‘medicine’, therefore, even if it’s not prescribed or ‘conventional’.

A study reviewed on f1000 this week examined acupuncture in the management of post-operative pain in children. Again, actually doing something to people had an effect; and this is with anaesthetized patients (so you might think that patient bias is reduced). This reminds me, parenthetically, of my favourite placebo story. Back in the Fifties a particular treatment for angina involved ligating certain arteries. When people did the proper experiment, they found that a sham procedure (under sedation, not anaesthetic) was just as effective, at least in the short term. Rather than say “hey, we’ve discovered something odd here” the surgeons stopped doing the procedure (that’s because they were medics, I presume. Were they scientists they might have played with the observation a bit). This also is not too surprising: acupuncture seems to work. We might not know how it does, but at least we can guess that the mechanism involves stimulation of certain nerves or release of endorphins, or something testable (but probably not some mysterious ‘life energy’):

For short-term outcomes, acupuncture showed significant superiority over sham for back pain, knee pain, and headache. For longer-term outcomes (6 to12 months), acupuncture was significantly more effective for knee pain and tension-type headache but inconsistent for back pain (one positive and one inconclusive).

The accumulating evidence from recent reviews suggests that acupuncture is more than a placebo for commonly occurring chronic pain conditions. If this conclusion is correct, then we ask the question: is it now time to shift research priorities away from asking placebo-related questions and shift toward asking more practical questions about whether the overall benefit is clinically meaningful and cost-effective?

And then we have the homeopaths. Bless them: although they say we can’t, or shouldn’t, test homeopathic ‘treatments’ like we test other CAM, sometimes they’ll go ahead anyway. And they’ll say things like

Piglets of the homeopathic treated group had significantly less E. coli diarrhoea than piglets in the placebo group (P < .0001).

Which, if true, would be brilliant.

But it’s not, is it? This is why they’re publishing in Homeopathy and not somewhere like Nature (because believe me, if it were true this would be Big News). Even so, that’s a remarkable claim, and I had a look at the paper to see what was going on.

It’s really rather simple. They treated (observer-blind, apparently. I guess the pigs didn’t know what they were getting) sows with either an homeopathic preparation or a placebo (or maybe vice versa. Hard to say). And then they scored the offspring of these sows for E. coli-caused diarrhoea. The piglets that had diarrhoea that wasn’t caused by E. coli didn’t get counted. Funnily enough, those pigs were all in the treatment group, which is how the authors managed to get a sixfold decrease and that rather splendid-looking p value. And how did they determine that those pigs weren’t suffering from that particular form of the squits? Well, it wasn’t by microbiology:

Faeces were cultured to identify enteropathogenic E. coli, E. coli K99 and Salmonella. None of these were identified as present in the faeces sample. This does not per se demonstrate that enteropathogenic E. coli were not present at the farm at that moment. It was a relatively small sample size of three litters, which would not necessarily include the infective agent. Because treatment with Coli 30C had worked before, and E. coli diarrhoea generally can be distinguished based on day of appearance and colour, this was not further investigated.

Translation: “We believed there was E. coli in these pigs. We failed to prove it, but that doesn’t matter because we are strong in the Force, and you should believe it too. And there was no way we were going to check the whole batch, because then we might find an inconvenient absence of what we want to prove.”

And seeing as they didn’t publish the raw data, who are we to argue anyway?

It’s hardly any wonder, with work of this ‘quality’ finding its way into the literature, that homeopaths are still making a fast buck through the gullibility of ordinary people. So I heartily commend to you the 1023 ‘Overdose’ event on Saturday 30th January. This is where a bunch of community-minded people are going to, en masse, swallow a whole bottle of some homeopathic pills to proof they’re ineffective. And to reward you, loyal reader, for making all this way to the end, here’s a joke:

Did you hear about the homeopathy patient who died of an overdose?

He forgot to take his medicine.

Posted in Medicine, Science | Tagged: , , , , , , , | 2 Comments »

Fitter healthier

Posted by rpg on 14 January, 2010

The necessary length of time from an initial scientific breakthrough to a tried and tested application, clinical or otherwise, can often tarnish the initial thrill of that first result, or even make you forget about it altogether. I have a photograph of my then three year old daughter sitting on the breakfast bar in the kitchen in our house in Cambridge, ‘reading’ the edition of Nature in which the first draft of the Human Genome sequence was published. It struck me, then, that I remembered the debate about whether we should sequence the genome, over ten years previously; and there we were, with the answer in our hands. (I still have that copy of Nature, as well as a New Scientist from when I was at high school which laid out the arguments for and against. I intend to blog about that elsewhere.)

Twelve years ago (check out that old-time BBC retro goodness!), the BBC carried a story that carried hope for a vaccine against cervical cancer:

Scientists believe they are on the verge of creating a vaccine to combat some forms of cancer.

It is hoped eventually the vaccine could be used on children.

Just half a year later the BBC again carried a story, this time with news of promising trials:

Scientists in Britain and the United States say they have made a breakthrough in finding a vaccine for cervical cancer which kills about a quarter of a million women throughout the world every year.
The scientists, in Manchester and Georgia, say trials on animals indicate that it could provide immunity to the virus which is responsible for ninety-five per-cent of cervical cancers in humans.

However it is expected to take about ten years of such trails and tests before a final judgement on its effectiveness can be made.

Worldwide, there are about 500,000 new cases of cervical cancer each year, and about a quarter of a million deaths from it. In developing countries (where nearly 80% of new cases occur), it is the most lethal form of cancer, and is responsible for one in ten cancer-related deaths globally. Compared with other cancers, it disproportionally affects younger women, causing substantial societal effects. An effective vaccine is therefore high on the wishlist for a lot of people.

Developing countries suffer highest cervical cancer mortality rates
Mortality rates per 100k from cervical cancer

Rather splendidly, then, just this week we published an evaluation of a paper in The Lancet describing the long-term efficacy of such a vaccination in a double-blind randomized control trial. The efficacy of the combined Human Papilloma Virus (HPV)-16/18 vaccine has already been demonstrated, having been ‘robustly’ estimated at 98%, but in the current paper it hits 100%*. Now that’s truly remarkable, but we need to realize that this was not a huge trial (n=349 in efficacy cohort, 340 in placebo), and so it lacks some statistical power. But perhaps more important than its efficacy, especially for developing countries where the cost and complexity of  booster vaccinations might be prohibitive, the long-term immune response turns out to be pretty outstanding, too.

Because the vaccine should be given to virgins (it is prophylactic; it does not protect against an existing infection), it has to be given to reasonably young girls, and needs (ideally) to last them throughout their sexually active life (which means until death, effectively). The current study only tracks women for six years four months, which you might think isn’t very long at all. However, after an early (in the first ~18 months) drop off in antibody titre the IgG antibody concentration remained stable in the vaccine group. The trial was not powerful enough (that is, not enough ‘accrued events’—i.e. neoplasms—occurred in the placebo group) to detect a small waning of efficacy over an extended period. Nonetheless, there is good reason to suspect the vaccination will remain effective for another ten years at least.

The HPV-16/18 vaccine is also safe—there was no significant difference in recorded events between vaccinated and placebo cohorts. Indeed, there were slightly more adverse events in the placebo group, and in a previous study, three women in the placebo cohort withdrew due to a non-serious adverse event; and the only withdrawal from the experimental cohort was due to a spontaneous (non-vaccine related) abortion.

Just before Christmas my daughter—the same one who sat in my kitchen with Nature—came home from school with a consent form. She got her first HPV jab soon after.

Score one more for science.

Read the rest of this entry »

Posted in Literature, Medicine | Tagged: , , , , , | 2 Comments »

Smells like teen spirit

Posted by rpg on 8 January, 2010

ResearchBlogging.org An interesting evaluation winged its way into Editorial over the Christmas break, and got waved under my nose ahead of publication. According to a paper published in J Clin Psychopharmacol last August, a double-blind placebo-controlled trial of oral chamomile extract showed a modest anxiolytic activity in patients with mild to moderate generalized anxiety disorder.

Despite the study’s small sample size (and the modesty of the authors) it seems to be a reasonable trial, and looks like chamomile is actually beneficial over placebo, in its first randomized, double-blind, placebo-controlled, parallel-group trial. This is big news for herbal therapies (yes Virginia, they do have active ingredients; unlike homeopathic prepartions).

However, the authors also say

We did not use a specific patient or clinician-rated measure
to verify the adequacy of the blinded conditions. Thus, it is possible that unrecognized rater or patient or clinician bias may have contributed to the superiority of chamomile over placebo

(my emphasis)

which leads me onto something a friend pointed out when I brought the paper to her notice. Chamomile has a reasonably strong and distinctive odour and flavour. If the preparation used retained either of these, then the placebo effect could still be in play.

I have finally managed to get hold of the full paper, however, and deep in the Materials section I find

Blinding of the characteristic chamomile aroma was achieved by inserting a disk impregnated with 1 drop of chamomile oil (for placebo) or 1 drop of neutral oil (for chamomile) into the lid of each airtight medication container

which is a great start, but I don’t know if it would be enough. Anyone have any thoughts on this?
Read the rest of this entry »

Posted in Medicine | Tagged: , , , , , | 7 Comments »

Our brains are the original energy savers

Posted by stevepog on 16 October, 2009

“Hippocampal mossy fibers” may sound like abnormal skin growths on a rare African mammal (to me at least) but they are actually axons of granule cells in the hippocampus which deal with different types of bevaviour such as spatial learning.

The region is also where scientists have discovered the brain’s ability to be energy efficient, detailed in a paper given a high rating by two of our F1000 Biology Faculty Members.

Environmentalists may not be initally be excited by the brain’s power saving nature but the potential is there for the concepts gained to be applied to tech products, as soon as someone with the medical and tech smarts can make the link.

It got me thinking (and I often branch off onto tangents so try to stay with me), what function of the body would be a brilliant thing to replicate? The brain is an obvious one and I won’t even consider genitalia as an answer but what other organs/systems could be reproduced in technological form to make daily life easier?

Similar to the brain’s energy saving ability, the body’s heating and cooling system would be a perfect one.  Airconditioning units may be getting more environmentally-friendly and better at regulating room temperature but as good as our office A/C system is, after about half an hour it leaves me either too hot or too cold.

A quick Google search comes up with thousands of personal heating and cooling products but despite the marketing hype, there’s still nothing out there that really replicates the body’s ability to adapt to the weather conditions.

Over to you :)

Posted in Medicine, f1000 | Tagged: , , , | Leave a Comment »